Violetta Dias Pacce

Monoclonal antibodies against LipL32 confer prophylactic protection against lethal leptospirosis challenge in animal model.

O. Dellagostin, D. Hartwig, M. Amaral, 2020, Microbial pathogenesis.

New age in vaccinology: the impact of the COVID-19 pandemic on third-generation vaccine development

E. L. P. Ramos, V. Thomaz-Soccol, R. Boschero, 2021, Biotechnology Research and Innovation.

Human and animal leptospirosis in Southern Brazil: A five-year retrospective study.

O. Dellagostin, T. Oliveira, R. Schuch, 2017, Travel medicine and infectious disease.

A novel chimeric protein composed of recombinant Mycoplasma hyopneumoniae antigens as a vaccine candidate evaluated in mice.

O. Dellagostin, T. Collares, L. G. Monte, 2017, Veterinary microbiology.

High-performance immune diagnosis of tuberculosis: Use of phage display and synthetic peptide in an optimized experimental design.

C. Soccol, V. Soccol, R. Boschero, 2022, Journal of immunological methods.

Peptides and current methods on bovine tuberculosis diagnosis

V. Thomaz-Soccol, O. Dellagostin, Violetta Dias Pacce, 2022, Biotechnology Research and Innovation.

Polymerase chain reaction and loop-mediated isothermal amplification targeting lic13162, lic20239, and lipL32 genes for leptospirosis diagnosis

N. Ikuta, V. Lunge, F. Kremer, 2022, Brazilian Journal of Microbiology.

A Review on COVID-19 Diagnosis Tests Approved for Use in Brazil and the Impact on Pandemic Control

C. Soccol, V. Soccol, V. Vicente, 2021, Brazilian Archives of Biology and Technology.